Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Survivin Isoform Expression in Arsenic Trioxide-Treated Acute Promyelocytic Leukemia Cell Line and Patients: The Odd Expression Pattern of Survivin-2Α Publisher Pubmed



Zaki Dizaji M1, 2 ; Ghaffari SH1 ; Hosseini E1 ; Alizadeh N1 ; Rostami S1 ; Momeny M1 ; Alimoghaddam K1 ; Ghavamzadeh A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Asia-Pacific Journal of Clinical Oncology Published:2017


Abstract

Aim: Survivin, an inhibitor of apoptosis protein, is overexpressed in most cancers and is associated with chemotherapy resistance, increased tumor recurrence and shorter patient survival. Several survivin splice variants have been described, and none of their expressions have been defined in acute promyelocytic leukemia (APL). Methods: Expression of the survivin gene isoforms (survivin, -2α, -2B, -ΔΕx3 and -3B) were analyzed in 50 peripheral blood and 19 bone marrow samples that were collected at different phases of the disease (diagnostic, remission and relapse) in APL patients treated with arsenic trioxide (ATO) as a front-line therapy. In addition, the human APL-derived cell line (NB4) was analyzed for the expression of survivin isoforms and capsase-3 in response to the ATO. Results: Survivin and its variants were overexpressed significantly in patient's bone marrow samples compared to peripheral blood or normal samples. Their expression was decreased after ATO treatment in both NB4 cells (except survivin-2α) and APL patients along with PML-RARα copy number reduction. Downregulation of survivin isoforms was associated with an increase in both caspase-3 gene expression and its enzymatic activity levels. In a patient who did not respond to ATO treatment, expression of survivin isoforms (except survivin-2α) were highly increased during the induction therapy. Conclusion: Survivin isoforms are upregulated in APL patients, and their expression is diminished during the ATO treatment. In addition, overexpression of survivin and its variants (except survivin-2α) are associated with unfavorable results, suggesting that they may play an important role in mechanisms underlying the resistance of APL cells to ATO. © 2016 John Wiley & Sons Australia, Ltd
Related Docs
1. Arsenic Trioxide Alters the Microrna Expression Profile of U87 Glioblastoma, Anti-Cancer Agents in Medicinal Chemistry (2016)
2. Survivin and Autoimmunity; the Ins and Outs, Immunology Letters (2018)
3. Overexpression of Apoptosis-Related Protein, Survivin, in Fibroblasts From Patients With Systemic Sclerosis, Irish Journal of Medical Science (2019)
4. Inhibition of Pi3k Pathway Using Bkm120 Intensified the Chemo-Sensitivity of Breast Cancer Cells to Arsenic Trioxide (Ato), International Journal of Biochemistry and Cell Biology (2019)
5. Demethylation and Alterations in the Expression Level of the Cell Cycle–Related Genes As Possible Mechanisms in Arsenic Trioxide–Induced Cell Cycle Arrest in Human Breast Cancer Cells, Tumor Biology (2017)
6. Micrornas Are Potentially Regulating the Survivin Gene in Pbmcs From Systemic Sclerosis Patients, Modern Rheumatology (2020)
7. Melatonin Promotes Ato-Induced Apoptosis in Mcf-7 Cells: Proposing Novel Therapeutic Potential for Breast Cancer, Biomedicine and Pharmacotherapy (2016)
8. Expression Analysis of Aurora-C and Survivin, Two Testis-Specific Genes, in Patients With Colorectal Cancer, Clinical Laboratory (2015)
Experts (# of related papers)
View all Related Experts
Ahmad Reza Jamshidi (3)
Mahdi Mahmoudi (3)